Results 271 to 280 of about 104,823 (289)

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

Annals of Oncology, 2016
T Denda, T Hirashima, I Hyodo
exaly  

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Annals of Oncology, 2015
D C Betticher, D Dietrich, R Winterhalder   +2 more
exaly  

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Oncologist, 2012
Auxiliadora Gomez-Espana, Albert Abad, Eugenio Marcuello   +2 more
exaly  

Management of bevacizumab-associated bowel perforation: a case series and review of the literature

Annals of Oncology, 2008
B Feig, Robert A Wolff, Charis Eng
exaly  

Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles

Journal of Controlled Release, 2019
Flavia Sousa, Harkiranpreet Kaur Dhaliwal, Bruno Sarmento   +2 more
exaly  

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial

Annals of Oncology, 2013
A Berglund, E Fernebro, A Jakobsen
exaly  

Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer

Cancer Cell, 2020
Ying Shen, Xiaohong Wang, Junyan Lu
exaly  

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Annals of Oncology, 2013
M Agulnik, S H Okuno, Margaret Von Mehren   +2 more
exaly  

The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review

Biomedicine and Pharmacotherapy, 2018
Dinesh Kumar Chellappan, Jestin Chellian, Gaurav Gupta   +2 more
exaly  

Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study

Annals of Oncology, 2018
Nicolaus Andratschke, Silvia Hofer, Sabine Rohrmann   +2 more
exaly